Invest
“There is always a winner in the hour of crisis”. It is not a hard nut to crack that the entire health industry (including its ancillary business verticals) has been the beneficiary of the COVID-19 pandemic, while the entire world was suffering. If IPO, instead of being 'Initial Public offering', would have been 'Immune Public Opportunity', pharma companies would have surely got mega listings; however, chances are that one of them might still get one.
Continue Reading
about 3 years ago